LRP4 and myasthenia gravis: However, LRP4 antibodies belong mostly to the IgG1 subclass (75, 78), and they have been shown to cause in vitro complement-mediated cell lysis of C2C12 myotubes (78), so complement activation could also play a role in MG patients.